Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Gastrointestinal » Inflammatory Bowel Disease 13. May 2026
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2879  Previews Next
   
   Articles 1 - 20 / 57565  
   
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.
J Gastroenterol Hepatol
Ooi CJ, Ling KL, Limsrivilai J, Wei SC, Mak JWY, Kobayashi T, Dang LM, Leong RW, Lin H, Weng MT, Ong WC, Ahuja V, Aniwan S, Hokari R, Lee WJJ, Leow AH, Leung WK, Lim WC, Makharia G, Matsuoka K, Mustaffa N, Ng SC, Philip M, Pisespongsa P, Ali RAR, Ran ZH, Simadibrata M, Sollano J, Tan M, Viet HD, Wan Ibrahim NR, Wu KC, Ye BD, Hilmi I, Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease Committee and Asian Education Network in IBD (AEN.
PMID: 42117726 [PubMed - as supplied by publisher]


Intestinal ultrasound reliably predicts fecal loading in patients with ulcerative colitis.
J Crohns Colitis
Mathias RM, Bogatic D, Edwards L, Bibb L, Van Oosterwyck A, Edwards S, Pathi R, Prowse S, Day AS, Goodsall T, Bryant RV.
PMID: 42117186 [PubMed - indexed for MEDLINE]


Comparative risk of serious infection in patients with ulcerative colitis treated with JAK inhibitors.
J Crohns Colitis
Meyer A, Bertrand A, Martin A, Carbonnel F, Amiot A.
PMID: 42117185 [PubMed - indexed for MEDLINE]


Crohn's Disease Activity Index in the era of obesity: time to abandon it?
J Crohns Colitis
Treton X, Stefanescu C, Mailhat C, Bouhnik Y, Vicaut E.
PMID: 42117184 [PubMed - indexed for MEDLINE]


A meta-analysis of the efficacy and safety of Janus kinase inhibitors in patients with ulcerative colitis.
Medicine (Baltimore)
Yang Q, Yan Y.
PMID: 42116395 [PubMed - indexed for MEDLINE]


Risk factors of inflammatory bowel disease complicating anemia: A systematic review and meta-analysis.
Medicine (Baltimore)
Niu Y, Zhang J, Chen S, Li Y.
PMID: 42116329 [PubMed - indexed for MEDLINE]


Specific alterations in the gut microbiome and metabolome across disease locations of Crohn's disease: a systematic review.
BMC Gastroenterol
Huang J, Chen Z, Chen M, Zeng Z, Zhuang X.
PMID: 42115865 [PubMed - as supplied by publisher]


Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.
J Crohns Colitis
Danese S, Dignass A, Laharie D, Limdi JK, Kempinski R, Lewis JD, Younes Z, Cohen E, Alaka K, Eastman WJ, Tian T, Redondo I, Rubin DT, Dubinsky M.
PMID: 42112567 [PubMed - indexed for MEDLINE]


A Real-World Study of Upadacitinib in Anti-TNF Refractory Crohn's Disease: Effectiveness, Persistence, and Safety.
J Inflamm Res
Fang Y, Zhou L, Li L, Zhang L, Zhu N, Hu J, Liu Q, Wu J, Zhang P, Mei Q, Han W.
PMID: 42112316 [PubMed]


Observational study of metastatic vulvar Crohn's disease in the pediatric population.
JPGN Rep
Winograd D, Addo A, Wassmer T, Hellmann J, Mallon D, Marathe K, Pennesi C.
PMID: 42110129 [PubMed]


EFFECTIVENESS OF RISANKIZUMAB AFTER USTEKINUMAB FAILURE IN CROHN'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY.
Gastroenterology
Mehta-Dhand S, Hamidi N, Clarke AN, Hoentjen F, Panaccione R, Ma C, IBD Clinics of the University of Calgary and University of Alberta.
PMID: 42107795 [PubMed - as supplied by publisher]


Comments on "Incidence and Neoplastic Risk Associated with Colonic Stricture in Paediatric-Onset Crohn's Disease: A Population-based Study".
Clin Res Hepatol Gastroenterol
Jaiswal A, Arya M, Sharma DB.
PMID: 42107598 [PubMed - as supplied by publisher]


Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease.
J Crohns Colitis
Noor NM, Zheng H, Cao Z, Caruso G, Voller C, Cooney R, Din S, Gordon H, Kok KB, Lindsay JO, Moran GW, Patel KV, Sebastian S, Raine T, Subramanian S, Hart AL, Robertson DS, Parkes M.
PMID: 42106904 [PubMed - indexed for MEDLINE]


Antibiotic Utilization for Perianal Fistulizing Complications Among Young Patients with Crohn's Disease.
J Pediatr
Gadepalli S, Tribble A, Rahman M, Manning L, Adler J.
PMID: 42105935 [PubMed - as supplied by publisher]


Soluble transferrin receptor as a reliable inflammation-independent marker of iron deficiency in Crohn's disease and ulcerative colitis.
Inflamm Bowel Dis
Portela F, Ministro P, de Sousa HT, Roseira J, Fernandes S, Crespo R, Domingues B, Santiago M, Melo-Miranda R, Dias S, Dias CC, Magro F.
PMID: 42105358 [PubMed - as supplied by publisher]


Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.
Adv Ther
Tursi A, Pasta A, Elisei W, Barberio B, Mocci G, Savarino EV, de Barba C, Maconi G, Cataletti G, Scaldaferri F, Napolitano D, Costa F, Ceccarelli L, Marzo M, Monterubbianesi R, di Fonzo M, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodino' S, Sebkova L, Bodini G, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Morano D, Gravina AG, Pellegrino R, Vespere G, Sedda S, Allegretta L, Fanigliulo L, Grossi L, Cortellini F, Forti G, Neve V, Piergallini S, Scarozza P, Bevevino G, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'antonio E, D'ascoli B, Colucci R, Bachetti F, Giorgetti GM, Clemente V, Pagnini C, Cuomo A, Donnarumma L, Onidi FM, Satta PU, Picchio M, Papa A, Italian Network for Inflammatory Bowel Diseases (IN-IBD).
PMID: 42105145 [PubMed - as supplied by publisher]


Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis.
United European Gastroenterol J
Hart A, Navabi S, D'Haens G, Matsuoka K, Martín-Arranz MD, Atreya R, Samaan KH, Dhesi E, Redondo I, Zhu B, Paulissen J, Zaremba-Pechmann L, Baygani S, Limdi J, Laharie D, Danese S.
PMID: 42104877 [PubMed - indexed for MEDLINE]


Εsophageal Crohn's disease in adults: A systematic review of the literature.
Surgery
Mela E, Garoufalia Z, Emile SH, Karangeli N, Mantziari S, Tagkalos E, Papanikolaou IS, Papaconstantinou I, Schizas D.
PMID: 42102534 [PubMed - as supplied by publisher]


Efficacy and safety of dietary supplements for the treatment of ulcerative colitis, a network meta-analysis.
Front Med (Lausanne)
Xu R, Zhang Z, Li Y, Wu Z.
PMID: 42100281 [PubMed]


Age-Related Microbiota Signatures in Inflammatory Diseases: Comparative Insights into Paediatric and Adult Crohn's Disease, Ulcerative Colitis, and Spondyloarthritis.
Mediterr J Rheumatol
Gimignani G, Borello A, Panetta C, Lucchetti L, Caorsi R, Gattorno M, Conforti A.
PMID: 42100057 [PubMed]


   
   Articles 1 - 20 / 57565    Page 1 of 2879  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1